HEADER HYDROLASE/INHIBITOR 21-MAR-16 5IVT TITLE CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH [(1S)-1-[(S)-(4- TITLE 2 CHLOROPHENYL)-(3,5-DIFLUOROPHENYL)METHYL]-2-[[5-FLUORO-4-[2-[(2R,5S)- TITLE 3 5-(2,2,2-TRIFLUOROETHYLCARBAMOYLOXYMETHYL)MORPHOLIN-4-IUM-2- TITLE 4 YL]ETHYL]PYRIDIN-1-IUM-3-YL]AMINO]-2-OXO-ETHYL]AMMONIUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HIV, PROTEASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.P.SU REVDAT 3 06-MAR-24 5IVT 1 REMARK REVDAT 2 10-AUG-16 5IVT 1 JRNL REMARK REVDAT 1 18-MAY-16 5IVT 0 JRNL AUTH C.J.BUNGARD,P.D.WILLIAMS,J.E.BALLARD,D.J.BENNETT,C.BEAULIEU, JRNL AUTH 2 C.BAHNCK-TEETS,S.S.CARROLL,R.K.CHANG,D.C.DUBOST,J.F.FAY, JRNL AUTH 3 T.L.DIAMOND,T.J.GRESHOCK,L.HAO,M.K.HOLLOWAY,P.J.FELOCK, JRNL AUTH 4 J.J.GESELL,H.P.SU,J.J.MANIKOWSKI,D.J.MCKAY,M.MILLER,X.MIN, JRNL AUTH 5 C.MOLINARO,O.M.MORADEI,P.G.NANTERMET,C.NADEAU,R.I.SANCHEZ, JRNL AUTH 6 T.SATYANARAYANA,W.D.SHIPE,S.K.SINGH,V.L.TRUONG, JRNL AUTH 7 S.VIJAYASARADHI,C.M.WISCOUNT,J.P.VACCA,S.N.CRANE, JRNL AUTH 8 J.A.MCCAULEY JRNL TITL DISCOVERY OF MK-8718, AN HIV PROTEASE INHIBITOR CONTAINING A JRNL TITL 2 NOVEL MORPHOLINE ASPARTATE BINDING GROUP. JRNL REF ACS MED.CHEM.LETT. V. 7 702 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 27437081 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00135 REMARK 2 REMARK 2 RESOLUTION. 1.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.22 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 82549 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4131 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5480 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1914 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5201 REMARK 3 BIN R VALUE (WORKING SET) : 0.1914 REMARK 3 BIN FREE R VALUE : 0.1917 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.09 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 279 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1516 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 195 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.47680 REMARK 3 B22 (A**2) : 0.94700 REMARK 3 B33 (A**2) : 0.52980 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.129 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.034 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.034 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.033 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.033 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1708 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2332 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 612 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 35 ; 8.000 ; HARMONIC REMARK 3 GENERAL PLANES : 265 ; 8.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1708 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 238 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2133 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.21 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.83 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.23 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -14.5706 11.3368 -12.9240 REMARK 3 T TENSOR REMARK 3 T11: -0.0103 T22: -0.0045 REMARK 3 T33: -0.0237 T12: 0.0006 REMARK 3 T13: 0.0017 T23: -0.0062 REMARK 3 L TENSOR REMARK 3 L11: 0.4868 L22: 0.3904 REMARK 3 L33: 0.8295 L12: -0.0182 REMARK 3 L13: 0.2427 L23: 0.1593 REMARK 3 S TENSOR REMARK 3 S11: 0.0092 S12: 0.0623 S13: -0.0221 REMARK 3 S21: -0.0375 S22: 0.0128 S23: -0.0075 REMARK 3 S31: 0.0192 S32: 0.0896 S33: -0.0220 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -13.0638 22.0789 5.3896 REMARK 3 T TENSOR REMARK 3 T11: -0.0066 T22: -0.0148 REMARK 3 T33: -0.0155 T12: -0.0005 REMARK 3 T13: -0.0016 T23: -0.0001 REMARK 3 L TENSOR REMARK 3 L11: 0.3610 L22: 0.6131 REMARK 3 L33: 0.6889 L12: 0.2826 REMARK 3 L13: 0.1913 L23: 0.4807 REMARK 3 S TENSOR REMARK 3 S11: -0.0163 S12: -0.0242 S13: 0.0287 REMARK 3 S21: -0.0057 S22: 0.0052 S23: 0.0355 REMARK 3 S31: -0.0188 S32: 0.0162 S33: 0.0111 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5IVT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000219522. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0-5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 82609 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.153 REMARK 200 RESOLUTION RANGE LOW (A) : 46.221 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.58200 REMARK 200 R SYM FOR SHELL (I) : 0.58200 REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NACL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.24000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.96500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.24000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.96500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 35 128.29 -39.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6EE A 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6EE B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 103 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IVS RELATED DB: PDB REMARK 900 RELATED ID: 5IVR RELATED DB: PDB REMARK 900 RELATED ID: 5IVQ RELATED DB: PDB DBREF 5IVT A 1 99 UNP C8B467 C8B467_9HIV1 1 99 DBREF 5IVT B 1 99 UNP C8B467 C8B467_9HIV1 1 99 SEQADV 5IVT LYS A 7 UNP C8B467 GLN 7 ENGINEERED MUTATION SEQADV 5IVT ILE A 33 UNP C8B467 LEU 33 ENGINEERED MUTATION SEQADV 5IVT ILE A 63 UNP C8B467 LEU 63 ENGINEERED MUTATION SEQADV 5IVT LYS B 7 UNP C8B467 GLN 7 ENGINEERED MUTATION SEQADV 5IVT ILE B 33 UNP C8B467 LEU 33 ENGINEERED MUTATION SEQADV 5IVT ILE B 63 UNP C8B467 LEU 63 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE HET ACT A 101 4 HET 6EE A 102 46 HET CL A 103 1 HET 6EE B 101 46 HET ACT B 102 4 HET CL B 103 1 HETNAM ACT ACETATE ION HETNAM 6EE (BETAS)-4-CHLORO-BETA-(3,5-DIFLUOROPHENYL)-N-(5-FLUORO- HETNAM 2 6EE 4-{2-[(2R,5S)-5-({[(2,2,2-TRIFLUOROETHYL) HETNAM 3 6EE CARBAMOYL]OXY}METHYL)MORPHOLIN-2-YL]ETHYL}PYRIDIN-3- HETNAM 4 6EE YL)-L-PHENYLALANINAMIDE HETNAM CL CHLORIDE ION FORMUL 3 ACT 2(C2 H3 O2 1-) FORMUL 4 6EE 2(C30 H30 CL F6 N5 O4) FORMUL 5 CL 2(CL 1-) FORMUL 9 HOH *195(H2 O) HELIX 1 AA1 GLY A 86 THR A 91 1 6 HELIX 2 AA2 GLN A 92 GLY A 94 5 3 HELIX 3 AA3 GLY B 86 THR B 91 1 6 SHEET 1 AA1 4 GLN A 2 ILE A 3 0 SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AA2 8 TRP A 42 GLY A 49 0 SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 AA2 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 AA2 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA2 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA3 8 LYS B 43 GLY B 49 0 SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLY B 52 N GLY B 49 SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 AA3 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 AA3 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA3 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SITE 1 AC1 6 ALA A 28 ASP A 29 ASP A 30 ILE A 47 SITE 2 AC1 6 6EE A 102 6EE B 101 SITE 1 AC2 30 ARG A 8 LEU A 23 ASP A 25 GLY A 27 SITE 2 AC2 30 ALA A 28 ASP A 29 ASP A 30 VAL A 32 SITE 3 AC2 30 GLY A 48 GLY A 49 ILE A 50 VAL A 82 SITE 4 AC2 30 ILE A 84 ACT A 101 HOH A 225 ARG B 8 SITE 5 AC2 30 LEU B 23 ASP B 25 GLY B 27 GLY B 48 SITE 6 AC2 30 GLY B 49 ILE B 50 PRO B 81 ILE B 84 SITE 7 AC2 30 6EE B 101 ACT B 102 HOH B 203 HOH B 228 SITE 8 AC2 30 HOH B 242 HOH B 303 SITE 1 AC3 4 THR A 74 ASN A 88 HOH A 282 ARG B 41 SITE 1 AC4 28 ARG A 8 LEU A 23 ASP A 25 GLY A 27 SITE 2 AC4 28 GLY A 48 GLY A 49 ILE A 50 PRO A 81 SITE 3 AC4 28 VAL A 82 ILE A 84 ACT A 101 6EE A 102 SITE 4 AC4 28 ARG B 8 LEU B 23 ASP B 25 GLY B 27 SITE 5 AC4 28 ALA B 28 ASP B 29 ASP B 30 VAL B 32 SITE 6 AC4 28 GLY B 48 GLY B 49 ILE B 50 VAL B 82 SITE 7 AC4 28 ILE B 84 ACT B 102 HOH B 228 HOH B 260 SITE 1 AC5 7 6EE A 102 ALA B 28 ASP B 29 ASP B 30 SITE 2 AC5 7 ILE B 47 GLY B 48 6EE B 101 SITE 1 AC6 1 TRP B 6 CRYST1 58.480 85.930 46.220 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017100 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011637 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021636 0.00000